SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001571049-16-017466
Filing Date
2016-08-15
Accepted
2016-08-15 09:16:10
Documents
46
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q t1601962_10q.htm 10-Q 246020
2 EXHIBIT 31.1 t1601962_ex31-1.htm EX-31.1 8741
3 EXHIBIT 32.1 t1601962_ex32-1.htm EX-32.1 4819
  Complete submission text file 0001571049-16-017466.txt   2570598

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE mrna-20160630.xml EX-101.INS 501698
5 XBRL SCHEMA FILE mrna-20160630.xsd EX-101.SCH 32576
6 XBRL CALCULATION FILE mrna-20160630_cal.xml EX-101.CAL 24987
7 XBRL DEFINITION FILE mrna-20160630_def.xml EX-101.DEF 133388
8 XBRL LABEL FILE mrna-20160630_lab.xml EX-101.LAB 273891
9 XBRL PRESENTATION FILE mrna-20160630_pre.xml EX-101.PRE 200688
Mailing Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021
Business Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021 4259083600
Marina Biotech, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-13789 | Film No.: 161830340
SIC: 2834 Pharmaceutical Preparations